Such a deal would give AZ shareholders a "substantial premium" (around 23%) to the share price before the M&A talks were revealed, as well a significant stake in the combined group, said Pfizer.
written on 28.04.2014
Such a deal would give AZ shareholders a "substantial premium" (around 23%) to the share price before the M&A talks were revealed, as well a significant stake in the combined group, said Pfizer.
See our Cookie Privacy Policy Here